| Prev Close | 9.31 |
| Day Low/High | 7.78 / 9.14 |
| 52 Wk Low/High | 2.08 / 10.89 |
Endo International Plc (ENDP)
7.93
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 230.29B |
| Market Cap | 2.14B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Endo International Shares Climb on Earnings Beat
Shares of the specialty-healthcare firm climbed on better-than-expected profits for the second quarter.
Trending Tickers: NCLH, RCL, ENDP, DISH
Norwegian Cruise Line was pulling down industry-peer Royal Caribbean Tuesday on lowered guidance.
Endo International Jumps on Patent Approval, Still Has Work to Do
ENDP shares surge on rare good news but asset sales may still be necessary.
Trending Tickers: UAL, MNK, ENDP, BWA
Optimism that the United Kingdom will remain part of the EU was tempered by falling oil prices.
Endo Could Be the Next Activist Target in Generics
Problems with mesh products and high leverage might scare away a potential buyer.
Teva Should Break Out of Droopy Drug Pack
Despite an earnings beat and upbeat outlook, its stock has suffered with other drug makers.
Jim Cramer: Allergan CEO Brent Saunders Is Doing a Great Job
Jim Cramer thinks Allergan CEO Brent Saunders has put together a world class company.
Endo International Plunges After Hours as Guidance Slashed
The specialty pharmaceutical company gave investors a lot of news to digest -- and they fled.
Endo's Asset Sale May Signal Litigation Trouble; Shares Trail S&P 500
the Sale of ASTORA Women's Health could bode well for the speciality pharma, as legal woes persist.
2 Great Biopharma Plays for a Shaky Market
Mylan and Endo International look like bargains at current prices.
4 Great Stock-ing Stuffers for 2016
These biotech/pharma picks could give you a very happy new year.
BioDelivery Is About to Start Delivering
The company cleared an important hurdle last month.
Apple Drives Markets on Icahn Boost; Altera Sparks Chipmaker Rally
Altera (ALTR) was the best performer on the S&P 500 Monday following reports the company has reopened negotiations with Intel (INTC).
Deluge of Deals Isn't About to Dry Up
Acquisitions cut into overabundance of companies.
Endo Buys Par Pharmaceutical; Intel, Altera Relaunch Deal Talks
Endo Pharmaceutical (ENDP) shares were on the move after the company agreed to buy privately-held Par Pharmaceutical Holdings for just over $8 billion in cash and stock.
Bear Chart of the Day: ENDP
Endo Pharmaceuticals could offer a short-term play.
Cramer: How Passive Is the S&P? (Part 2)
Take a look at some more of its recent moves.
2 Solid Trees to Withstand This Storm
It's wise to stick with strength right now.
Merger Mania Benefits Mylan
Whether it's acquiring or the acquired, Mylan is building shareholder value.
Will Valeant Overdose on Acquisitions?
This rollup name is on the stock-market equivalent of steroids.
5 Dumbest Things on Wall Street
Avon Gets Dinged, Endo's Irish Eyes, Piper Pipes Down, Bye-Bye BlackBerry and Walmart Gone Wild highlight Gregg Greenberg's list this week.
